The Chicken Chorioallantoic Membrane Model in Biology, Medicine and Bioengineering

Overview

Journal Angiogenesis

Publisher Springer

Specialty Hematology

Date 2014 Aug 21

PMID 25138280

Citations 196

Authors

Patrycja Nowak-Sliwinska

Tatiana Segura

M Luisa Iruela-Arispe

Affiliations

Soon will be listed here.

Abstract

The chicken chorioallantoic membrane (CAM) is a simple, highly vascularized extraembryonic membrane, which performs multiple functions during embryonic development, including but not restricted to gas exchange. Over the last two decades, interest in the CAM as a robust experimental platform to study blood vessels has been shared by specialists working in bioengineering, development, morphology, biochemistry, transplant biology, cancer research and drug development. The tissue composition and accessibility of the CAM for experimental manipulation, makes it an attractive preclinical in vivo model for drug screening and/or for studies of vascular growth. In this article we provide a detailed review of the use of the CAM to study vascular biology and response of blood vessels to a variety of agonists. We also present distinct cultivation protocols discussing their advantages and limitations and provide a summarized update on the use of the CAM in vascular imaging, drug delivery, pharmacokinetics and toxicology.

Citing Articles

Vascularised organoids: Recent advances and applications in cancer research.

Zhou R, Brislinger D, Fuchs J, Lyons A, Langthaler S, Hauser C Clin Transl Med. 2025; 15(3):e70258.

PMID: 40045486 PMC: 11882480. DOI: 10.1002/ctm2.70258.

In Vitro and In Ovo Evaluation of L. Oil as an Alternative Preservative for Oil-Based Products.

Fecker R, Avram S, Cocan I, Alexa E, Bora L, Minda D Foods. 2025; 14(2).

PMID: 39856999 PMC: 11765098. DOI: 10.3390/foods14020332.

The Chicken Embryo: An Old but Promising Model for In Vivo Preclinical Research.

Sarnella A, Ferrara Y, Terlizzi C, Albanese S, Monti S, Licenziato L Biomedicines. 2025; 12(12.

PMID: 39767740 PMC: 11673736. DOI: 10.3390/biomedicines12122835.

Mammary Cancer Models: An Overview from the Past to the Future.

Silva J, Oliveira P, Duarte J, Faustino-Rocha A In Vivo. 2024; 39(1):1-16.

PMID: 39740866 PMC: 11705154. DOI: 10.21873/invivo.13800.

Phytochemical, Antioxidant, Antimicrobial and Safety Profile of L. Extract Obtained from Romania.

Semenescu I, Avram S, Similie D, Minda D, Diaconeasa Z, Muntean D Plants (Basel). 2024; 13(23).

PMID: 39683057 PMC: 11644507. DOI: 10.3390/plants13233265.

References

Parsons-Wingerter P, Lwai B, Yang M, Elliott K, Milaninia A, Redlitz A . A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvasc Res. 1998; 55(3):201-14. DOI: 10.1006/mvre.1998.2073. View

Warnock G, Turtoi A, Blomme A, Bretin F, Bahri M, Lemaire C . In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: a new tool for oncology and radiotracer development. J Nucl Med. 2013; 54(10):1782-8. DOI: 10.2967/jnumed.112.117150. View

Ribatti D, Guidolin D, Conconi M, Nico B, Baiguera S, Parnigotto P . Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo. Oncogene. 2003; 22(41):6458-61. DOI: 10.1038/sj.onc.1206789. View

van Beijnum J, Nowak-Sliwinska P, van den Boezem E, Hautvast P, Buurman W, Griffioen A . Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene. 2012; 32(3):363-74. DOI: 10.1038/onc.2012.49. View

Gorski D, Mauceri H, Salloum R, Halpern A, Seetharam S, Weichselbaum R . Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy. Cancer Res. 2003; 63(2):308-11. View

Piffaretti F, Novello A, Kumar R, Forte E, Paulou C, Nowak-Sliwinska P . Real-time, in vivo measurement of tissular pO2 through the delayed fluorescence of endogenous protoporphyrin IX during photodynamic therapy. J Biomed Opt. 2012; 17(11):115007. DOI: 10.1117/1.jbo.17.11.115007. View

Strick D, Waycaster R, Montani J, Gay W, Adair T . Morphometric measurements of chorioallantoic membrane vascularity: effects of hypoxia and hyperoxia. Am J Physiol. 1991; 260(4 Pt 2):H1385-9. DOI: 10.1152/ajpheart.1991.260.4.H1385. View

Wong C, Inman E, Spaethe R, Helgerson S . Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost. 2003; 89(3):573-82. View

Barile F . Validating and troubleshooting ocular in vitro toxicology tests. J Pharmacol Toxicol Methods. 2010; 61(2):136-45. PMC: 2849866. DOI: 10.1016/j.vascn.2010.01.001. View

10.

Chin W, Lau W, Bhuvaneswari R, Heng P, Olivo M . Chlorin e6-polyvinylpyrrolidone as a fluorescent marker for fluorescence diagnosis of human bladder cancer implanted on the chick chorioallantoic membrane model. Cancer Lett. 2006; 245(1-2):127-33. DOI: 10.1016/j.canlet.2005.12.041. View

11.

DAGG C, KARNOFSKY D, Roddy J . Growth of transplantable human tumors in the chick embryo and hatched chick. Cancer Res. 1956; 16(7):589-94. View

12.

Wacker B, Scott E, Kaneda M, Alford S, Elbert D . Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogels. Biomacromolecules. 2006; 7(4):1335-43. PMC: 2522266. DOI: 10.1021/bm050948r. View

13.

Vazquez F, Hastings G, Ortega M, Lane T, Oikemus S, Lombardo M . METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem. 1999; 274(33):23349-57. DOI: 10.1074/jbc.274.33.23349. View

14.

Deryugina E, Zijlstra A, Partridge J, Kupriyanova T, Madsen M, Papagiannakopoulos T . Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination. Cancer Res. 2005; 65(23):10959-69. DOI: 10.1158/0008-5472.CAN-05-2228. View

15.

Pegaz B, Debefve E, Ballini J, Wagnieres G, Spaniol S, Albrecht V . Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model. Eur J Pharm Sci. 2006; 28(1-2):134-40. DOI: 10.1016/j.ejps.2006.01.008. View

16.

Borges J, Tegtmeier F, Padron N, Mueller M, Lang E, Stark G . Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. Tissue Eng. 2003; 9(3):441-50. DOI: 10.1089/107632703322066624. View

17.

Nazarov A, Baquie M, Nowak-Sliwinska P, Zava O, van Beijnum J, Groessl M . Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters. Sci Rep. 2013; 3:1485. PMC: 6504821. DOI: 10.1038/srep01485. View

18.

Brooks P, Montgomery A, Rosenfeld M, Reisfeld R, Hu T, Klier G . Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994; 79(7):1157-64. DOI: 10.1016/0092-8674(94)90007-8. View

19.

Barrie R, Woltering E, Hajarizadeh H, Mueller C, Ure T, FLETCHER W . Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. J Surg Res. 1993; 55(4):446-50. DOI: 10.1006/jsre.1993.1167. View

20.

Ribatti D, Cruz A, Nico B, Favier J, Vacca A, Corsi P . In situ hybridization and immunogold localization of vascular endothelial growth factor receptor-2 on the pericytes of the chick chorioallantoic membrane. Cytokine. 2002; 17(5):262-5. DOI: 10.1006/cyto.2002.1002. View